Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shiwei Ruxiang Wan
- Development stage
- Unknown
- Lead developer
- Xizang Ganlu Tibetan Medicine
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Shiwei Ruxiang Wan is a traditional Tibetan medicine (TTM) developed and manufactured by Xizang Ganlu Tibetan Medicine. It is formulated as an oral pill containing ten active ingredients, with Frankincense (*Boswellia carterii*) serving as a primary component alongside others such as *Terminalia chebula* and *Acorus calamus*. In the framework of Tibetan medicine, it is specifically indicated for "yellow water" (Chu-ser) disorders, which correspond to inflammatory conditions involving joint effusion and skin exudation. The drug is primarily used to treat rheumatoid arthritis, gout, and inflammatory skin diseases like eczema and psoriasis. It functions by exerting anti-inflammatory and analgesic effects, helping to reduce joint swelling, alleviate pain, and dry up pathological fluid accumulations.
- Brand names
- Ganlu
- Other names
- 十味乳香丸Ten-Flavor Frankincense PillsShiwei Ruxiang PillsShiwei Ruxiang Wan
02
Targets
NLRP3 (Nod-like receptor family pyrin domain-containing protein 3)
Beyond the preview
Go deeper on Shiwei Ruxiang Wan.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shiwei Ruxiang Wan.